Sechenov School
Home › Microbiology › Autoimmune Diseases

Autoimmune Diseases

Morbi autoimmunes

For medical students2 min readUpdated 2026-10-10

Autoimmune diseases are pathological conditions in which the immune system mistakenly attacks the body's own healthy tissues. A failure of self-recognition leads to the formation of autoreactive cell clones and autoantibodies, causing inflammation and organ damage.

Core MechanismBreakdown of tolerance to self-antigens and autoantibody-mediated aggression.
SpecificityClassified into organ-specific (single target) and systemic (broad spectrum).
Genetic RoleProven association with major histocompatibility complex (HLA) genes.
Basis of TherapyUse of anti-inflammatory and cytotoxic drugs.

Mechanisms and Classification

Normally, the immune system destroys foreign antigens or altered self-cells (e.g., tumor cells). In autoimmune diseases, this process malfunctions. Autoreactive lymphocyte clones are formed, and autoantibodies and cytotoxic T cells are generated against healthy tissues.

Diseases are divided into two main groups:

Frequently, a single individual may present with multiple concurrent autoimmune pathologies.

Etiology and Risk Factors

Autoimmune diseases have a multifactorial etiology, triggered by a combination of external and internal factors.

Exogenous (External) Factors:

Endogenous (Internal) Factors:

Role of Infections and Immune-Privileged Organs

Infectious agents can trigger pathology via two main pathways. The first is molecular mimicry, where microbial proteins structurally resemble human proteins, causing antibodies to mistakenly target host tissues. The second pathway involves the pathogen altering the structure of the body's own antigens, rendering them foreign to the immune system.

A special mechanism involves immune-privileged organs. Normally, certain tissues (brain, eye, thyroid gland, testes) are separated from the immune system by blood-tissue barriers, and lymphocytes do not typically contact them. If trauma or inflammation disrupts the barrier, the immune system encounters these antigens for the first time, perceives them as foreign, and launches an autoimmune reaction.

Principles of Treatment

The baseline therapeutic strategy aims to suppress the pathological immune response.

  1. Anti-inflammatory and cytotoxic drugs form the backbone of therapy.
  2. Glucocorticoids (GCs). Used during acute flares. Pulse therapy (ultra-high doses of GCs combined with cytotoxics) is an option, though it carries severe side effects.
  3. Targeted (biological) therapy. Includes anticytokine agents (blocking inflammatory mediators) and cellular receptor suppression.
  4. Aminoquinoline derivatives (hydroxychloroquine, chloroquine). Exhibit anti-inflammatory, antioxidant, and photoprotective properties. Prescribed in the absence of severe organ damage.

Frequently asked questions

Which conditions are classified as systemic autoimmune pathologies?

Systemic autoimmune pathologies include conditions where aggression is directed against autoantigens present in many tissues throughout the body. Examples include:

  • Systemic lupus erythematosus (SLE).
  • Rheumatoid arthritis.
  • Multiple sclerosis.
What mechanisms lead to the breakdown of natural immunological tolerance?

The breakdown of natural immunological tolerance occurs under the influence of various triggers via several pathogenetic mechanisms, including:

  • Molecular mimicry — structural similarity between infectious agent proteins and self-autoantigens.
  • Alteration of self-antigen structure induced by microorganisms.
  • Production of anti-idiotypic antibodies.
  • Polyclonal lymphocyte activation — non-specific stimulation of B lymphocytes by infectious agents.
  • Increased immunogenicity of self-structures, inducing an immune response.
  • Disruption of natural barriers of immune-privileged sites due to trauma or inflammation, bringing antigens into contact with immune effectors.
Which specific anticytokine drugs are used in targeted therapy for autoimmune diseases?

Targeted anticytokine therapy utilizes:

  • Infliximab — a monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-alpha).
  • Anakinra — a recombinant antagonist that competitively blocks interleukin-1 (IL-1) receptors.
  • Etanercept — a soluble TNF receptor acting as a decoy protein.
What is the difference between systemic and organ-specific autoimmune diseases?

In an organ-specific disease, the immune system attacks only one specific organ (e.g., the thyroid gland). In a systemic disease, autoantibodies target antigens present across numerous tissues throughout the body (such as in systemic lupus erythematosus).

Why can eye trauma cause an autoimmune disease?

The eye is an immune-privileged organ, meaning its tissues are normally isolated from the immune system. Trauma disrupts this barrier, allowing eye antigens to enter the bloodstream, prompting the immune system to attack them as foreign.

How does an infection trigger an autoimmune process?

An infection can act via molecular mimicry (where microbial proteins resemble human tissues) or by altering the body's own antigens so they are no longer recognized as 'self'.

Go deeper

More topics in Microbiology

Microsporidia and MicrosporidiosisTrypanosoma: Morphology, Life Cycle, and PathogenesisBasics of ImmunologyAir MicrofloraGenetic EngineeringUrogenital Tract ImmunityOutcomes and Classification of Infectious ProcessesBiological Diagnostic MethodPathogenesis and Clinical Features of Acute Respiratory Infections (ARI)Pathogenesis of Anaplasmosis and EhrlichiosisTinea Nigra Agent: Phaeoanellomyces werneckiiSubcutaneous MycosesMicrobiology →